The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics
Open accessAbstract
Extensive efforts have been directed at the discovery, investigation and clinical monitoring of targeted therapeutics. These efforts may be facilitated by the convenient access of the genetic, proteomic, interactive and other aspects of the therapeutic targets. Here, we describe an update of the Therapeutic target database (TTD) previously featured in NAR. This update includes: (i) 2000 drug resistance mutations in 83 targets and 104 target/drug regulatory genes, which are resistant to 228 drugs targeting 63 diseases (49 targets of 61 drugs with patient prevalence data); (ii) differential expression profiles of 758 targets in the disease-relevant drug-targeted tissue of 12 615 patients of 70 diseases; (iii) expression profiles of 629 targets in the non-targeted tissues of 2565 healthy individuals; (iv) 1008 target combinations of 1764 drugs and the 1604 target combination of 664 multi-target drugs; (v) additional 48 successful, 398 clinical trial and 21 research targets, 473 approved, 812 clinical trial and 1120 experimental drugs, and (vi) ICD-10-CM and ICD-9-CM codes for additional 482 targets and 262 drugs against 98 disease conditions. This update makes TTD more useful for facilitating the patient focused research, discovery and clinical investigations of the targeted therapeutics. TTD is accessible at http://bidd.nus.edu.sg/group/ttd/ttd.asp.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
Database resources of the National Center for Biotechnology Information: update
Wheeler, D. L. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh073 · Cited by 10,641
NCBI GEO: archive for functional genomics data sets—update
Barrett, T., Wilhite, S. E., Ledoux, P., Evangelista, C., Kim, I. F., Tomashevsky, M., Marshall, K. A., Phillippy, K. H., Sherman, P. M., Holko, M., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1193 · Cited by 10,418
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,266
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
KEGG as a reference resource for gene and protein annotation
Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M., & Tanabe, M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1070 · Cited by 7,387
affy—analysis of Affymetrix GeneChip data at the probe level
Gautier, L., Cope, L., Bolstad, B. M., & Irizarry, R. A. (2004) · Bioinformatics · doi:10.1093/bioinformatics/btg405 · Cited by 5,218
UniProt: a hub for protein information
The UniProt Consortium (2015) · Nucleic Acids Research · doi:10.1093/nar/gku989 · Cited by 5,106
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rupaimoole, R., & Slack, F. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.246 · Cited by 4,741
Hauschild, A., Grob, J.-J., Demidov, L. V., Jouary, T., Gutzmer, R., Millward, M., Rutkowski, P., Blank, C. U., Miller, W. H., Kaempgen, E., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60868-x · Cited by 2,989
CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database
Jia, B., Raphenya, A. R., Alcock, B., Waglechner, N., Guo, P., Tsang, K. K., Lago, B. A., Dave, B. M., Pereira, S., Sharma, A. N., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1004 · Cited by 2,661
A comprehensive map of molecular drug targets
Santos, R., Ursu, O., Gaulton, A., Bento, A. P., Donadi, R. S., Bologa, C. G., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T. I., et al. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.230 · Cited by 2,427
Gaulton, A., Hersey, A., Nowotka, M., Bento, A. P., Chambers, J., Mendez, D., Mutowo, P., Atkinson, F., Bellis, L. J., Cibrián-Uhalte, E., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1074 · Cited by 2,330
DrugBank 4.0: shedding new light on drug metabolism
Law, V., Knox, C., Djoumbou, Y., Jewison, T., Guo, A. C., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M., Neveu, V., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1068 · Cited by 1,993
COSMIC: somatic cancer genetics at high-resolution
Forbes, S. A., Beare, D., Boutselakis, H., Bamford, S., Bindal, N., Tate, J., Cole, C. G., Ward, S., Dawson, E., Ponting, L., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1121 · Cited by 1,922
Lessons from 60 years of pharmaceutical innovation
Munos, B. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2961 · Cited by 1,207
Analysis of Microarray Data Using Z Score Transformation
Cheadle, C., Vawter, M. P., Freed, W. J., & Becker, K. G. (2003) · The Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60455-2 · Cited by 1,146
Multi-target therapeutics: when the whole is greater than the sum of the parts
Zimmermann, G. R., Lehár, J., & Keith, C. T. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.11.008 · Cited by 1,105
Southan, C., Sharman, J. L., Benson, H. E., Faccenda, E., Pawson, A. J., Alexander, S. P. H., Buneman, O. P., Davenport, A. P., McGrath, J. C., Peters, J. A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1037 · Cited by 1,035
Mechanisms of drug combinations: interaction and network perspectives
Jia, J., Zhu, F., Ma, X., Cao, Z. W., Li, Y. X., & Chen, Y. Z. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2683 · Cited by 969
Self-citationTrends in the exploitation of novel drug targets
Rask-Andersen, M., Almén, M. S., & Schiöth, H. B. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3478 · Cited by 853
Drugs, their targets and the nature and number of drug targets
Imming, P., Sinning, C., & Meyer, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2132 · Cited by 839
Database Resources of the National Center for Biotechnology Information
Coordinators, N. R. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1071 · Cited by 817
The efficiency of multi-target drugs: the network approach might help drug design
CSERMELY, P., AGOSTON, V, & PONGOR, S. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.02.007 · Cited by 803 · cited 4×
“and the novel treatment strategies such as multitarget drugs (25,26,31), drug combinations (27,28,52), monoclonal antibodies (61) and RNA therapeutics (62) for enhanced therapeutics and for overcoming drug resistances (21,22).”
BackgroundInfluentialTTD: Therapeutic Target Database
Chen, X. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.412 · Cited by 716
Building better monoclonal antibody-based therapeutics
Weiner, G. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3930 · Cited by 712
Bell, D. W., Gore, I., Okimoto, R. A., Godin-Heymann, N., Sordella, R., Mulloy, R., Sharma, S. V., Brannigan, B. W., Mohapatra, G., Settleman, J., et al. (2005) · Nature Genetics · doi:10.1038/ng1671 · Cited by 531
Tuberculosis Drug Resistance Mutation Database
Sandgren, A., Strong, M., Muthukrishnan, P., Weiner, B. K., Church, G. M., & Murray, M. B. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000002 · Cited by 523
Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery
Zhu, F., Shi, Z., Qin, C., Tao, L., Liu, X., Xu, F., Zhang, L., Song, Y., Liu, X., Zhang, J., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr797 · Cited by 480
Self-citationCATH: comprehensive structural and functional annotations for genome sequences
Sillitoe, I., Lewis, T. E., Cuff, A., Das, S., Ashford, P., Dawson, N. L., Furnham, N., Laskowski, R. A., Lee, D., Lees, J. G., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku947 · Cited by 423
Strategies for optimizing combinations of molecularly targeted anticancer agents
Dancey, J. E., & Chen, H. X. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2089 · Cited by 365
NOREVA: normalization and evaluation of MS-based metabolomics data
Li, B., Tang, J., Yang, Q., Li, S., Cui, X., Li, Y., Chen, Y., Xue, W., Li, X., & Zhu, F. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx449 · Cited by 352
Self-citationA global map of human gene expression
Lukk, M., Kapushesky, M., Nikkilä, J., Parkinson, H., Goncalves, A., Huber, W., Ukkonen, E., & Brazma, A. (2010) · Nature Biotechnology · doi:10.1038/nbt0410-322 · Cited by 350
DrugCentral: online drug compendium
Ursu, O., Holmes, J., Knockel, J., Bologa, C. G., Yang, J. J., Mathias, S. L., Nelson, S. J., & Oprea, T. I. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw993 · Cited by 323 · cited 1×
“In particular, a number of freely accessible databases complementarily provide comprehensive information about the therapeutic targets with additional information about the clinical trial drugs (11–13), biomarkers (11), molecular activity data (11,13–15), drug-binding sites (16,17) and targetaffiliated biological path…”
BackgroundJSME: a free molecule editor in JavaScript
Bienfait, B., & Ertl, P. (2013) · Journal of Cheminformatics · doi:10.1186/1758-2946-5-24 · Cited by 304
Update of TTD: Therapeutic Target Database
Zhu, F., Han, B., Kumar, P., Liu, X., Ma, X., Wei, X., Huang, L., Guo, Y., Han, L., Zheng, C., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp1014 · Cited by 274
Self-citationYang, H., Qin, C., Li, Y. H., Tao, L., Zhou, J., Yu, C. Y., Xu, F., Chen, Z., Zhu, F., & Chen, Y. Z. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1230 · Cited by 270
Self-citationClustered patterns of species origins of nature-derived drugs and clues for future bioprospecting
Zhu, F., Qin, C., Tao, L., Liu, X., Shi, Z., Ma, X., Jia, J., Tan, Y., Cui, C., Lin, J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107336108 · Cited by 255
Self-citationMacLean, R. C., Hall, A. R., Perron, G. G., & Buckling, A. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2778 · Cited by 247
Kummar, S., Chen, H. X., Wright, J., Holbeck, S., Millin, M. D., Tomaszewski, J., Zweibel, J., Collins, J., & Doroshow, J. H. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3216 · Cited by 247
Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms
Hughes, D., & Andersson, D. I. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3922 · Cited by 245
The influence of subclonal resistance mutations on targeted cancer therapy
Schmitt, M. W., Loeb, L. A., & Salk, J. J. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.175 · Cited by 223
Therapeutic Targets: Progress of Their Exploration and Investigation of Their Characteristics
Zheng, C. J., Han, L. Y., Yap, C. W., Ji, Z. L., Cao, Z. W., & Chen, Y. Z. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.2.4 · Cited by 185
Self-citationLi, B., Tang, J., Yang, Q., Cui, X., Li, S., Chen, S., Cao, Q., Xue, W., Chen, N., & Zhu, F. (2016) · Scientific Reports · doi:10.1038/srep38881 · Cited by 171
Self-citationLeveraging big data to transform target selection and drug discovery
Chen, B., & Butte, A. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.318 · Cited by 160
Drug-Induced Regulation of Target Expression
Iskar, M., Campillos, M., Kuhn, M., Jensen, L. J., van Noort, V., & Bork, P. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000925 · Cited by 159
The HIVdb System for HIV-1 Genotypic Resistance Interpretation
Tang, M. W., Liu, T. F., & Shafer, R. W. (2012) · Intervirology · doi:10.1159/000331998 · Cited by 153
Using reverse docking for target identification and its applications for drug discovery
Lee, A., Lee, K., & Kim, D. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1190706 · Cited by 151
Therapeutic target database update 2014: a resource for targeted therapeutics
Chu, Q., Zhang, C., Zhu, F., Xu, F., Chen, S. Y., Zhang, P., Li, Y., Yang, S. Y., Wei, Y., Tao, L., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1129 · Cited by 122
Self-citationXue, W., Wang, P., Li, B., Li, Y., Xu, X., Yang, F., Yao, X., Chen, Y., Xu, F., & Zhu, F. (2015) · Physical Chemistry Chemical Physics · doi:10.1039/c5cp05771j · Cited by 105
Self-citationDCDB: Drug combination database
Liu, Y., Hu, B. X., Cheng‐Xin, F. U., & Chen, X. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp697 · Cited by 103
ccmGDB: a database for cancer cell metabolism genes
Kim, P., Cheng, F., Zhao, J., & Zhao, Z. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1128 · Cited by 61
Wang, P., Zhang, X., Fu, T., Li, S., Li, B., Xue, W., Yao, X., Chen, Y., & Zhu, F. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00173 · Cited by 60
Self-citationComputer prediction of drug resistance mutations in proteins
Cao, Z., Han, L., Zheng, C., Ji, Z., Chen, X., Lin, H., & Chen, Y. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03377-5 · Cited by 60
Self-citationTao, L., Zhu, F., Xu, F., Chen, Z., Jiang, Y., & Chen, Y. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.09.019 · Cited by 56
Self-citationWang, P., Fu, T., Zhang, X., Yang, F., Zheng, G., Xue, W., Chen, Y., Yao, X., & Zhu, F. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.07.022 · Cited by 56
Self-citationZhu, F., Han, L., Zheng, C., Xie, B., Tammi, M. T., Yang, S., Wei, Y., & Chen, Y. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.149955 · Cited by 50
Self-citationWang, C., Hu, G., Wang, K., Bryliński, M., Xie, L., & Kurgan, L. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv597 · Cited by 48
Identification of Cancer Related Genes Using a Comprehensive Map of Human Gene Expression
Torrente, A., Lukk, M., Xue, V., Parkinson, H., Rung, J., & Brāzma, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157484 · Cited by 44
Systematic Analysis of Drug Targets Confirms Expression in Disease-Relevant Tissues
Kumar, V. D., Sanséau, P., Simola, D. F., Hurle, M. R., & Agarwal, P. (2016) · Scientific Reports · doi:10.1038/srep36205 · Cited by 31
Ito, J.-I., Ikeda, K., Yamada, K., Mizuguchi, K., & Tomii, K. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1144 · Cited by 30
Zhang, X., Song, J., Bork, P., & Zhao, X. (2016) · Scientific Reports · doi:10.1038/srep20558 · Cited by 16
Self-citation
Cited by
Wang, Y., Zhang, S., Li, F., Zhou, Y., Zhang, Y., Wang, Z., Zhang, R., Zhu, J., Ren, Y., Tan, Y., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz981 · Cited by 794
Self-citationZhou, Y., Zhang, Y., Lian, X., Li, F., Wang, C., Zhu, F., Qiu, Y., & Chen, Y. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab953 · Cited by 665
Self-citationTTD: Therapeutic Target Database describing target druggability information
Zhou, Y., Zhang, Y., Zhao, D., Yu, X., Shen, X., Zhou, Y., Wang, S., Qiu, Y., Chen, Y., & Zhu, F. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkad751 · Cited by 645
Self-citationTrans-ethnic association study of blood pressure determinants in over 750,000 individuals
Understanding Society Scientific Group, Giri, A., International Consortium for Blood Pressure, Blood Pressure-International Consortium of Exome Chip Studies, Program, M. V., Hellwege, J. N., Keaton, J. M., Park, J., Qiu, C., Warren, H. R., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0303-9 · Cited by 459
Machine learning approaches and databases for prediction of drug–target interaction: a survey paper
Bagherian, M., Sabeti, E., Wang, K., Sartor, M. A., Nikolovska-Coleska, Z., & Najarian, K. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbz157 · Cited by 429
Metadata
- Authors
- Li, Y. H., Yu, C. Y., Li, X. X., Zhang, P., Tang, J., Yang, Q., Fu, T., Zhang, X., Cui, X., Tu, G., Zhang, Y., Li, S., Yang, F., Sun, Q., Qin, C., Zeng, X., Chen, Z., Chen, Y. Z., & Zhu, F.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-11-13
- Volume
- 46
- Issue
- D1
- Pages
- D1121-D1127
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2787229753
- Cited by
- 523
- References
- 62
- FWCI
- 56.44
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.